Featured Publications
Spatial Variability in the Persistence of Pneumococcal Conjugate Vaccine-targeted Pneumococcal Serotypes Among Adults
Warren JL, Pingali SC, Weinberger DM. Spatial Variability in the Persistence of Pneumococcal Conjugate Vaccine-targeted Pneumococcal Serotypes Among Adults. Epidemiology 2017, 28: 119-126. PMID: 27541841, PMCID: PMC5131859, DOI: 10.1097/ede.0000000000000551.Peer-Reviewed Original ResearchConceptsVaccine-targeted serotypesInvasive pneumococcal disease casesPneumococcal disease casesDirect vaccinationDisease casesInvasive pneumococcal diseaseConjugate vaccinePneumococcal diseaseVaccine serotypesVaccine uptakePneumococcal serotypesLeading causeBaseline proportionRate of declineNumber of casesAdult populationVaccinationStudy periodVaccineSerotypesAdultsChildrenHigh levelsMorbidityGeographic regions
2025
Estimating the Serotype-Specific Association Between the Concentration of Vaccine-Induced Serum Antibodies and Protection Against Pneumococcal Colonization
Wong A, Warren J, Fitch L, Perniciaro S, Dagan R, Weinberger D. Estimating the Serotype-Specific Association Between the Concentration of Vaccine-Induced Serum Antibodies and Protection Against Pneumococcal Colonization. The Journal Of Infectious Diseases 2025, jiaf106. PMID: 40036886, DOI: 10.1093/infdis/jiaf106.Peer-Reviewed Original ResearchHigher-valent PCVsPneumococcal conjugate vaccinePneumococcal colonizationVaccine-induced serum antibodiesRisk of colonizationSerum immunoglobulin GRandomized controlled trialsConjugate vaccinePCV13Clinical trialsSerum IgGImmune responseVaccinated childrenSevere diseaseVaccine effectivenessSerum antibodiesPCV20Serotype-specificImmunoglobulin GSerotypesColonIndirect protectionIgGVaccineTrials
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply